| Zacks Company Profile for AstraZeneca PLC (AZN : NSDQ) |
|
|
| |
| • Company Description |
| AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.
Number of Employees: 94,300 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $67.57 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 4,989,227 shares |
| Shares Outstanding: 3,101.25 (millions) |
| Market Capitalization: $209,551.27 (millions) |
| Beta: 0.40 |
| 52 Week High: $87.68 |
| 52 Week Low: $61.24 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
1.93% |
-3.41% |
| 12 Week |
-8.17% |
-0.79% |
| Year To Date |
3.13% |
7.17% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS
-
CAMBRIDGE,X0 CB2 0AA
GBR |
ph: 44-20-3749-5000
fax: 44-12-2335-2858 |
ir@astrazeneca.com |
http://www.astrazeneca.com |
|
|
| |
| • General Corporate Information |
Officers
Pascal Soriot - Chief Executive Officer
Leif Johansson - Chairman
Aradhana Sarin - Chief Financial Officer
Philip Broadley - Director
Euan Ashley - Director
|
|
Peer Information
AstraZeneca PLC (CORR.)
AstraZeneca PLC (RSPI)
AstraZeneca PLC (CGXP)
AstraZeneca PLC (BGEN)
AstraZeneca PLC (GTBP)
AstraZeneca PLC (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 046353108
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/24/25
|
|
Share - Related Items
Shares Outstanding: 3,101.25
Most Recent Split Date: 7.00 (2.00:1)
Beta: 0.40
Market Capitalization: $209,551.27 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 3.05% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.12 |
Indicated Annual Dividend: $2.06 |
| Current Fiscal Year EPS Consensus Estimate: $4.50 |
Payout Ratio: 0.48 |
| Number of Estimates in the Fiscal Year Consensus: 7.00 |
Change In Payout Ratio: -0.01 |
| Estmated Long-Term EPS Growth Rate: 12.14% |
Last Dividend Paid: 02/21/2025 - $1.03 |
| Next EPS Report Date: 07/24/25 |
|
|
|
| |
